Patents by Inventor Jean Bedard

Jean Bedard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Histone deacetylase inhibitors for enhancing activity of antifungal agents
    Patent number: 8759400
    Abstract: The present invention relates to compositions and methods to selectively treat fungal infection. More particularly, this invention relates to compositions and methods for selectively enhancing fungal sensitivity to antifungal compounds.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: June 24, 2014
    Assignee: MethylGene Inc.
    Inventors: Nafsika Georgopapadakou, Wenqi Hu, Nadia Campeol, Jean Bedard, Robert Deziel, Alain Ajamian
  • COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
    Publication number: 20130123242
    Abstract: The present invention provides novel compounds represented by formula I: or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection.
    Type: Application
    Filed: October 26, 2012
    Publication date: May 16, 2013
    Applicant: Vertex Pharmaceuticals (Canada) Incorporated
    Inventors: Laval Chan Chun Kong, Jean Bedard, Sanjoy Kumar Das, Nghe Nguyen-Ba, Oswy Z. Pereira, Thumkunta Jagadeeswar Reddy, Mohammad Arshad Siddiqui, Wuyi Wang, Constantin G. Yannopoulos
  • Compounds and methods for the treatment or prevention of infections
    Patent number: 8329924
    Abstract: The present invention provides novel compounds represented by formula I: or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection.
    Type: Grant
    Filed: April 7, 2011
    Date of Patent: December 11, 2012
    Assignee: Vertex Pharmaceuticals (Canada) Incorporated
    Inventors: Laval Chan Chun Kong, Jean Bedard, Sanjoy Kumar Das, Nghe Nguyen-Ba, Oswy Z. Pereira, Thumkunta Jagadeeswar Reddy, Mohammad Arshad Siddiqui, Wuyi Wang, Constantin G. Yannopoulos
  • COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
    Publication number: 20110200553
    Abstract: The present invention provides novel compounds represented by formula I: or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection.
    Type: Application
    Filed: April 7, 2011
    Publication date: August 18, 2011
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventors: Laval Chan Chun Kong, Jean Bedard, Sanjoy Kumar Das, Nghe Nguyen Ba, Oswy Z. Pereira, Thumkunta Jagadeeswar Reddy, Mohammed Arshad Siddiqui, Wuyi Wang, Constanin G. Yannopoulos
  • Compounds and methods for the treatment or prevention of infections
    Patent number: 7985769
    Abstract: The present invention provides novel compounds represented by formula I: or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection.
    Type: Grant
    Filed: January 26, 2005
    Date of Patent: July 26, 2011
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Laval Chan Chun Kong, Jean Bedard, Sanjoy Kumar Das, Nghe Nguyen Ba, Oswy Z. Pereira, Thumkunta Jagadeeswar Reddy, Mohammad Arshad Siddiqui, Wuyi Wang, Constanin Yannopoulos
  • Histone deacetylase inhibitors for enhancing activity of antifungal agents
    Publication number: 20070197550
    Abstract: The present invention relates to compositions and methods to selectively treat fungal infection. More particularly, this invention relates to compositions and methods for selectively enhancing fungal sensitivity to antifungal compounds.
    Type: Application
    Filed: December 19, 2006
    Publication date: August 23, 2007
    Inventors: Nafsika Georgopapadakou, Wenqi Hu, Nadia Campeol, Jean Bedard, Robert Deziel, Alain Ajamian
  • Compounds and methods for the treatment or prevention of Flavivirus infections
    Publication number: 20060142347
    Abstract: The present invention provides novel compounds represented by formula I: or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection.
    Type: Application
    Filed: January 26, 2005
    Publication date: June 29, 2006
    Inventors: Laval Chan Chun Kong, Jean Bedard, Sanjoy Das, Nghe Nguyen Ba, Oswy Pereira, Thumkunta Reddy, Mohammad Siddiqui, Wuyi Wang, Constanin Yannopoulos
  • Method for the treatment or prevention of viral infection using nucleoside analogues
    Patent number: 6964968
    Abstract: Viral infections selected from the group consisting of herpes simplex virus, varicella zoster virus, respiratory syncytial virus and cytomegalovirus can be treated by administering to the host a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof; wherein Y, Ra, and R1 are as defined herein. The compounds and salts can also be used to inhibit viral replication of these viruses in cells.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: November 15, 2005
    Assignee: Shire Biochem, Inc.
    Inventors: Francis J. Giles, Jean Bédard, Robert F. Rando
  • Compounds and methods for the treatment or prevention of Flavivirus infections
    Patent number: 6887877
    Abstract: The present invention provides novel compounds represented by formula I: or pharmaceutically acceptable salts thereof useful for treating Flaviviridae viral infection.
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: May 3, 2005
    Assignee: ViroChem Pharma Inc.
    Inventors: Laval Chan Chun Kong, Jean Bedard, Sanjoy Kumar Das, Nghe Nguyen Ba, Oswy Z. Pereira, Stephen Joseph Shuttleworth, Mohammad Arshad Siddiqui, Wuyi Wang
  • Compounds and methods for the treatment or prevention of Flavivirus infections
    Patent number: 6881741
    Abstract: The present invention provides novel compounds represented by formula I: or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection.
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: April 19, 2005
    Assignee: ViroChem Pharma Inc.
    Inventors: Laval Chan Chun Kong, Jean Bedard, Sanjoy Kumar Das, Nghe Nguyen Ba, Oswy Z. Pereira, Thumkunta Jagadeeswar Reddy, Mohammad Arshad Siddiqui, Wuyi Wang, Constanin Yannopoulos
  • COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
    Publication number: 20040116509
    Abstract: The present invention provides novel compounds represented by formula I: 1
    Type: Application
    Filed: June 11, 2002
    Publication date: June 17, 2004
    Applicant: Shire BioChem Inc.
    Inventors: Laval Chan Chun Kong, Jean Bedard, Sanjoy Kumar, Nghe Nguyen Ba, Oswy Z. Pereira, Thumkunta Jagadeeswar Reddy, Mohammad Arshad Siddiqui, Wuyi Wang, Constantin Yannopoulos
  • Method for the treatment or prevention of viral infection using nucleoside analogues
    Publication number: 20040014757
    Abstract: The present invention relates to uses and methods for treating or preventing a viral infection selected from the group consisting of herpes simple virus, varicella zoster virus, respiratory syncytial virus and cytomegalovirus in a host comprising using a therapeutically effective amount of a compound having the formula I or a pharmaceutically acceptable salt thereof. The present invention also includes pharmaceutical compositions and combinations.
    Type: Application
    Filed: March 31, 2003
    Publication date: January 22, 2004
    Applicant: BioChem Pharma Inc.
    Inventors: Francis J. Giles, Jean Bedard, Robert F. Rando
  • Compounds and methods for the treatment or prevention of flavivirus infections
    Publication number: 20030229053
    Abstract: the present invention provides novel compounds represented by formula I: 1
    Type: Application
    Filed: June 11, 2002
    Publication date: December 11, 2003
    Applicant: Shire BioChem Inc.
    Inventors: Laval Chan Chun Kong, Jean Bedard, Sanjoy Kumar Das, Nghe Nguyen Ba, Oswy Z. Pereira, Stephen Joseph Shuttleworth, Mohammad Arshad Siddiqui, Wuyi Wang
  • Method for the treatment or prevention of viral infection using nucleoside analogues
    Patent number: 6583149
    Abstract: Compounds of formula I: wherein Y, X, R1 and Ra are defined herein are in methods for treating or preventing a viral infections selected from herpes simplex virus, varicella zoster virus, respiratory syncytial virus and cytomegalovirus infections.
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: June 24, 2003
    Assignee: BioChem Pharma Inc.
    Inventors: Francis J. Giles, Jean Bédard, Robert F. Rando
  • Antiviral compounds
    Patent number: 6534520
    Abstract: The present invention relates to heterocyclic Compounds having antiviral activity. In particular, Compounds of formula (I): wherein B, W, X, Y, Q, R1, R2, R3, R4 and n are as defined herein, are useful in the therapy and prophylaxis of viral infection in mammals.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: March 18, 2003
    Assignee: BioChem Pharma Inc.
    Inventors: Jean Bédard, Robert Rando, Jean-Francois Lavallée, Guy Falardeau
  • Macrocyclic anti-viral compounds
    Publication number: 20020137733
    Abstract: The present invention relates to heterocyclic compounds having antiviral activity.
    Type: Application
    Filed: December 26, 2001
    Publication date: September 26, 2002
    Inventors: Guy Falardeau, Laval Chan Chun Kong, Jean Bedard
  • Antiviral compounds
    Publication number: 20010031765
    Abstract: The present invention relates to heterocyclic Compounds having antiviral activity.
    Type: Application
    Filed: February 5, 2001
    Publication date: October 18, 2001
    Applicant: BioChem Pharma Inc.
    Inventors: Jean Bedard, Robert Rando, Jean-Francois Lavallee, Guy Falardeau
  • Antiviral compounds
    Patent number: 6255318
    Abstract: The present invention relates to heterocyclic Compounds having antiviral activity. In particular, Compounds of formula (I): wherein B, W, X, Y, Q, R1, R2, R3, R4 and n are as defined herein, are useful in the therapy and prophylaxis of viral infection in mammals.
    Type: Grant
    Filed: December 11, 1998
    Date of Patent: July 3, 2001
    Assignee: Biochem Pharma Inc.
    Inventors: Jean Bédard, Robert Rando, Jean-Francois Lavallée, Guy Falardeau
  • Steerable rail-bogie
    Patent number: 5199359
    Abstract: A twin-axle rail-bogie which incorporates a steering mechanism for positively steering one or both of the axles of the rail-bogie in proportion to the rotation of the frame of a structure supported by this rail-bogie. Steering is achieved by slidably mounting one of the axle end supporting assemblies onto the chassis of the bogie so that this assembly is longitudinally slidable and thus causes the one axle having one of its ends connected thereto to pivot forwards or rearwards out of its normal transverse position relative to the transversally opposite supporting assembly which holds the other end of the one axle and then acts as a pivot. An operating arm attached to the frame near the one supporting assembly is used for moving via a linking mechanism the one supporting assembly in such a direction as to cause the one axle held by this supporting assembly to pivot in the same direction but at an angle smaller than and proportional to the frame with respect to the chassis of the bogie.
    Type: Grant
    Filed: May 20, 1992
    Date of Patent: April 6, 1993
    Assignee: Innotermodal Inc.
    Inventors: Jean Bedard, Jacques Viens